will optimise decision-making for liver cancer patients by identifying genomic prognostic determinants and oncogenic drivers.
’s core team comprises leading European researchers in the basic, translational and clinical fields of liver cancer.
is a 3-year translational research project which aims to solve core problems in the management of hepatocellular carcinoma (HCC), the third most common cause of cancer-related death worldwide.----
----
Invitation
Every year the United European Gastroenterology (UEG) National Societies Committee and the Scientific Committee jointly select up to 10 emerging clinical scientists. In the 2013 edition of the Rising Star awards two IDIBAPS investigators are among the winners: Dr.Augusto Villanueva, from the IDIBAPS Hepatocellular Carcinoma Translational Research Lab (BCLC group), and Dr. Francesc Balaguer, from the IDIBAPS Gastrointestinal and Pancreatic Oncology team.
The awarded researchers are young and highly qualified professionals from around Europe with a relevant international-quality research. This initiative provides a durable platform for young researchers so that they can give state-of-the-art lectures and chair scientific sessions at UEG Week. The next one will take place on October 12-16, in Berlin.
Prof. Jessica Zucman-Rossi, MD, PhD
Monday, 11/22/2010
Barcelona
Friday, 01/27/2012
Berlin, Germany
Xu MZ, Chan SW, Liu AM, Wong KF, Fan ST, Chen J, Poon RT, Zender L, Lowe SW, Hong W, Luk JM.
Berdasco M, Esteller M.
Gaujoux S, Pinson S, Gimenez-Roqueplo AP, Amar L, Ragazzon B, Launay P, Meatchi T, Libé R, Bertagna X, Audebourg A, Zucman-Rossi J, Tissier F, Bertherat J.
Clinical expertise
Copyright © 2010 - 2013 HEPTROMIC
HEPTROMIC is a project in the 'Health' Theme of the Specific Programme 'Cooperation' of the European Commission's Seventh Framework Programme.